Acute eosinophilic pneumonia after allogeneic hematopoietic stem cell transplantation

Clicks: 258
ID: 113803
2006
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #19 of 85 articles by views in Annals of hematology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A 55-year old woman with multiple myeloma was treated with hematopoietic stem cell transplantation (HSCT). She developed cutaneous and hepatic graft-vs-host disease (GVHD). Sixty-five days after HSCT, acute respiratory failure occurred. A thoracic computed tomography scan showed bilateral patchy infiltrates. Bronchoalveolar lavage revealed 40% eosinophils on differential cell count with no infectious pathogens. These findings were in favor of acute eosinophilic pneumonia. High-dose steroid treatment was started, which had a rapid and lasting favorable course. After HSCT, clinicians should be aware that acute eosinophilic pneumonia mimics infectious pneumonitis and can be associated with GVHD.
Reference Key
wagner2006annalsacute Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Thierry Wagner;Nathalie Dhedin;Bruno Philippe;Elisabeth Rivaud;Jean Paul Vernant;Louis-Jean Couderc;Thierry Wagner;Nathalie Dhedin;Bruno Philippe;Elisabeth Rivaud;Jean Paul Vernant;Louis-Jean Couderc;
Journal Annals of hematology
Year 2006
DOI
doi:10.1007/s00277-005-0068-y
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.